250 related articles for article (PubMed ID: 24754976)
21. Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model.
Alawieh M; Rifle G; Bouchot O; Malapert G; Mousson C; Martin L
Transplant Proc; 2009 Oct; 41(8):3363-6. PubMed ID: 19857750
[TBL] [Abstract][Full Text] [Related]
22. CD4-mediated functional activation of human CD4+CD25+ regulatory T cells.
Becker C; Kubach J; Wijdenes J; Knop J; Jonuleit H
Eur J Immunol; 2007 May; 37(5):1217-23. PubMed ID: 17407195
[TBL] [Abstract][Full Text] [Related]
23. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
24. In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression.
Liberal R; Grant CR; Holder BS; Cardone J; Martinez-Llordella M; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2015 Sep; 62(3):863-75. PubMed ID: 25953611
[TBL] [Abstract][Full Text] [Related]
25. In vitro induced CD4(+)CD25(+)Foxp3(+) Tregs attenuate hepatic ischemia-reperfusion injury.
Lu L; Li G; Rao J; Pu L; Yu Y; Wang X; Zhang F
Int Immunopharmacol; 2009 May; 9(5):549-52. PubMed ID: 19539564
[TBL] [Abstract][Full Text] [Related]
26. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells.
Ukena SN; Grosse J; Mischak-Weissinger E; Buchholz S; Stadler M; Ganser A; Franzke A
Ann Hematol; 2011 Feb; 90(2):213-8. PubMed ID: 20859740
[TBL] [Abstract][Full Text] [Related]
27. Disruption of TIM-4 in dendritic cell ameliorates hepatic warm IR injury through the induction of regulatory T cells.
Li J; Zhao X; Liu X; Liu H
Mol Immunol; 2015 Aug; 66(2):117-25. PubMed ID: 25771178
[TBL] [Abstract][Full Text] [Related]
28. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M
Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710
[TBL] [Abstract][Full Text] [Related]
29. Depletion of CD4+CD25+CD127lo regulatory T cells does not increase allergen-driven T cell activation.
Skrindo I; Farkas L; Kvale EO; Johansen FE; Jahnsen FL
Clin Exp Allergy; 2008 Nov; 38(11):1752-9. PubMed ID: 18681851
[TBL] [Abstract][Full Text] [Related]
30. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
[TBL] [Abstract][Full Text] [Related]
31. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
32. Presensitized immune condition of host exaggerates prolonged cold ischemia-mediated injury of cardiac graft involving regulatory T cells.
Gong W; Huang T; Ge F; Luo G; Yuan S; Gao D; Kong D
Transplantation; 2013 Oct; 96(7):609-15. PubMed ID: 23880577
[TBL] [Abstract][Full Text] [Related]
33. Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy.
Zhao JX; Zeng YY; Liu Y
J Reprod Immunol; 2007 Oct; 75(2):71-81. PubMed ID: 17686527
[TBL] [Abstract][Full Text] [Related]
34. The P2X7 receptor antagonist, oxidized adenosine triphosphate, ameliorates renal ischemia-reperfusion injury by expansion of regulatory T cells.
Koo TY; Lee JG; Yan JJ; Jang JY; Ju KD; Han M; Oh KH; Ahn C; Yang J
Kidney Int; 2017 Aug; 92(2):415-431. PubMed ID: 28396117
[TBL] [Abstract][Full Text] [Related]
35. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.
Bossowski A; Moniuszko M; Dąbrowska M; Sawicka B; Rusak M; Jeznach M; Wójtowicz J; Bodzenta-Lukaszyk A; Bossowska A
Autoimmunity; 2013 May; 46(3):222-30. PubMed ID: 23249428
[TBL] [Abstract][Full Text] [Related]
36. Expansion of CD4+CD25+ suppressive regulatory T cells from rhesus macaque peripheral blood by FN18/antihuman CD28-coated Dynal beads.
Gansuvd B; Asiedu CK; Goodwin J; Jargal U; Deckard LA; Andrades P; Guarcello V; Thomas JM
Hum Immunol; 2007 Jun; 68(6):478-90. PubMed ID: 17509447
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo induced regulatory T cells regulate inflammatory response of Kupffer cells by TGF-beta and attenuate liver ischemia reperfusion injury.
Feng M; Wang Q; Zhang F; Lu L
Int Immunopharmacol; 2012 Jan; 12(1):189-96. PubMed ID: 22155100
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
40. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
Jiang S; Tsang J; Lechler RI
Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
